Page 2 - Constantine Tam News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Constantine Tam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Constantine Tam Today - Breaking & Trending Today

BeiGene Presents Results from SEQUOIA Trial of BRUKINSA (zanubrutinib) in First-Line Chronic Lymphocytic Leukemia at the 63rd ASH Annual Meeting

Published: December 12, 2021

CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--Dec 12, 2021--

Source: cadillacnews.com

Related Topics:

United StatesUnited Arab EmiratesSaudi ArabiaUnited KingdomJane HuangConstantine TamGrande Ospedale Metropolitano NiguardaAlessandra TedeschiGabrielle ZhouNational Cancer InstitutePeter Maccallum Cancer CenterExchange CommissionAmerican Society For HematologyEuropean UnionCancer Support CommunityNational Cancer IncidenceBristol Myers SquibbAmerican Cancer SocietyAmerican SocietyBusiness WireChief Medical OfficerPrimary EndpointOverall SafetyMany GradeAnnual Meeting

Updated NCCN Guidelines Now Include Zanubrutinib for WM

Published: November 4, 2021

The new second-generation BTK inhibitor zanubrutinib is a preferred regimen for the treatment of symptomatic Waldenstrom's macroglobulinemia.

Source: medscape.com

Related Topics:

United StatesConstantine TamSteven TreonInternational Workshop On Waldenstrom MacroglobulinemiaInternational Waldenstrom Macroglobulinemia Foundation Educational ForumPeter Maccallum Cancer CentreDrug AdministrationHealth CanadaHarvard Medical SchoolNational Comprehensive Cancer NetworkInternational WaldenstromMacroglobulinemia Foundation EducationalMedscape Medical NewsInternational WorkshopWaldenstrom HypergammaglobulinemiaAlignant NeoplasiaClinical GuidelinesClinical ManagementClinical PathologyClinical ResearchClinical TrialsLinical StudiesMonoclonal AntibodyBiologic TherapyBiologic Therapy In Cancer